Skip to main content

Krueger Christopher W's Form 4 filing

Ventyx Biosciences, Inc. (VTYX) · filed Jul 5, 2023

Accession no.
0001209191-23-041353
Filed
Jul 5, 2023, 8:18 PM ET
Trade date
Jun 5-Jul 3, 2023
Filing delay
30 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $588.3K. It was filed 30 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001209191-23-044662 (Aug 4, 2023). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krueger Christopher WCIK 0001394208Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 3, 2023Common StockMOption exerciseAcquired+1,089$8.04+$8,755.56277,637Direct
Jul 3, 2023Common StockMOption exerciseAcquired+13,911$0.20+$2,782.2291,548Direct
Jul 3, 2023Common StockSSaleDisposed−403$33.57F2−$13,527.54291,145Direct
Jul 3, 2023Common StockSSaleDisposed−214$34.72F3−$7,430.51290,931Direct
Jul 3, 2023Common StockSSaleDisposed−40$35.50F4−$1,419.88290,891Direct
Jul 3, 2023Common StockSSaleDisposed−1,960$38.05F5−$74,573.49288,931Direct
Jul 3, 2023Common StockSSaleDisposed−2,150$38.79F6−$83,399.15286,781Direct
Jul 3, 2023Common StockSSaleDisposed−10,233$39.87F7−$407,992.78276,548Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 5, 2023Common StockMOption exerciseDisposed−1,089$0.00$0149,371Direct
Jun 5, 2023Common StockMOption exerciseDisposed−13,911$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average share price of an aggregate total of 403 shares sold in the price range of $33.23 to $34.1212. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average share price of an aggregate total of 214 shares sold in the price range of $34.2599 to $35.2093. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $35.2747 to $35.7192. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average share price of an aggregate total of 1,960 shares sold in the price range of $37.2788 to $38.2782. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents the weighted average share price of an aggregate total of 2,150 shares sold in the price range of $38.2802 to $39.28. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents the weighted average share price of an aggregate total of 10,233 shares sold in the price range of $39.2812 to $40.05. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)